Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

S1753Referred to Committee

End Price Gouging for Medications Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-05-14
Introduced
3
Cosponsors
S
ⓘ
Type

Sponsor

Jeff Merkley
Jeff Merkley
Democrat · OR · Senator
Votes with party: 65.3% (323 recorded votes)

Full profile: /officials/M001176

Source: Congress.gov · FEC

Cosponsors (3)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

3 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2025-05-14

Source: Congress.gov

Committee Activity

Currently in

  • Senate Committee on Health, Education, Labor, and PensionsReferred To · 2025-05-14

Plain-English Summary

The proposal would allow the federal government to investigate and take action against pharmaceutical companies that dramatically raise drug prices without justification, particularly during emergencies or public health crises. It would give regulators tools to prevent sudden, extreme price increases on existing medications that patients depend on, affecting both individual consumers and insurance companies that pay for prescriptions. The measure aims to make essential medicines more affordable while still allowing companies to profit from their products.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • S4618Elementary and Secondary School Counseling Act
    Referred to Committee · 2026-05-21
  • S4597Early Childhood Workforce Advancement Act of 2026
    Referred to Committee · 2026-05-20
  • S4568Nursing is a Professional Degree Act
    Referred to Committee · 2026-05-19
  • SJRES163A joint resolution to direct the removal of United States Armed Forces from hostilities within or against the Islamic Republic of Iran that have not been authorized by Congress.
    Referred to Committee · 2026-05-13